Go back
“We established EURÊKA Foundation at the same time as ARCHIMED, driven by our core mission of investing in healthcare industries to improve health outcomes for patients. EURÊKA not only benefits from ARCHIMED’s financial support but, most importantly, it draws upon the dedicated time and energy of our team. Philanthropy is a core part of ARCHIMED’s identity and one of the key reasons why many team members joined us.”
Vincent Guillaumot is a Managing Partner at ARCHIMED and President of the EURÊKA Foundation, ARCHIMED’s charitable foundation. He is a Board Member of Clubhouse International. Vincent has a long-standing relationship with other ARCHIMED Partners, since 2005.
Vincent holds close to 20 years of experience in the healthcare and private equity sectors. He began his career at Bain & Company as a consultant before joining 3i’s healthcare team. Prior to joining ARCHIMED, Vincent was the Managing Director of JS Bio (now Cerba HealthCare), a European medical diagnostics lab network.
Vincent currently holds board positions with a Germany-based tissue diagnostics group specializing in Immunohistochemistry (IHC) and In Situ Hybridization (ISH), ZYTOMICS, a US-based software company, Title21, a UK-based provider of software and tech-enabled services for the life sciences industry, Instem, an Italy-based manufacturer of aesthetic medicine, GPQ (WiQo), a US-based medical device solutions provider, Natus, a France-based international leader in hemostasis and thrombosis analysis solutions, Stago, and a US-based developer and manufacturer of in vitro diagnostic (IVD) immunoassay reagents, ARK Diagnostics.
PORTFOLIO COMPANIES
